{"id":50609,"date":"2022-11-08T14:02:47","date_gmt":"2022-11-08T13:02:47","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/"},"modified":"2022-11-08T14:02:47","modified_gmt":"2022-11-08T13:02:47","slug":"pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/","title":{"rendered":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting"},"content":{"rendered":"
\n

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA.\n<\/p>\n

\nPoster Presentation Details:<\/b>\n<\/p>\n

\nTitle:<\/b> \u201cDiscovery of remyelination therapeutics that overcome the effects of inflammatory macrophages on oligodendrocyte formation\u201d
\n
<\/i>Poster Number: <\/b>194.11
\n
Session Title<\/b>: Mechanisms and Therapeutics of Demyelinating and Peripheral Nerve Disorders
\n
Date\/Time: <\/b>November 13, 2022, 1:00 PM – 5:00 PM\n<\/p>\n

\nTitle:<\/b> \u201cPIPE-791, a potent brain-penetrant selective LPA1 antagonist, reduces neuroinflammation in vivo\u201d
\n
<\/i>Poster Number: <\/b>377.27
\n
Session Title<\/b>: Mechanisms of Neurodegeneration and Neuroprotective Therapies
\n
Date\/Time: <\/b>November 14, 2022, 1:00 PM – 5:00 PM\n<\/p>\n

\nMore information can be found on the meeting website at SFN Meeting 2022 | 12-16 Nov 2022 | San Diego, USA<\/a>.\n<\/p>\n

\nAbout Pipeline Therapeutics<\/b>\n<\/p>\n

\nPipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair. The Company has a broad pipeline of programs to address multiple CNS disorders. Its flagship program, PIPE-307, has completed two Phase 1 clinical trials – a SAD\/MAD study and a PET study – in healthy volunteers, and has received Investigational New Drug clearance from the Food and Drug Administration to initiate clinical development in relapsing-remitting MS patients.\n<\/p>\n

\nFor more information, please visit www.pipelinetherapeutics.com<\/a> and engage with us on LinkedIn.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nCompany Contact:<\/b>
Peter Slover
\n
CFO
\n
ir@pipeline-tx.com<\/a>\n<\/p>\n

\nInvestor Contact:<\/b>
Amy Conrad
\n
858-914-1962
\n
amy@juniper-point.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA. Poster Presentation Details: Title: \u201cDiscovery of remyelination therapeutics that overcome the effects of inflammatory macrophages on oligodendrocyte formation\u201d Poster Number: … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50609","6":"format-standard","7":"category-industry"},"yoast_head":"\nPipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA. Poster Presentation Details: Title: \u201cDiscovery of remyelination therapeutics that overcome the effects of inflammatory macrophages on oligodendrocyte formation\u201d Poster Number: ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T13:02:47+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting\",\"datePublished\":\"2022-11-08T13:02:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/\"},\"wordCount\":245,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/\",\"name\":\"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-11-08T13:02:47+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend","og_description":"SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that it will present two posters at the SFN 2022 Neuroscience Annual Meeting, taking place November 12-16, 2022, in San Diego, CA. Poster Presentation Details: Title: \u201cDiscovery of remyelination therapeutics that overcome the effects of inflammatory macrophages on oligodendrocyte formation\u201d Poster Number: ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-08T13:02:47+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting","datePublished":"2022-11-08T13:02:47+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/"},"wordCount":245,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/","name":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-11-08T13:02:47+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pipeline Therapeutics to Present Multiple Posters at SFN 2022 Neuroscience Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50609","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50609"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50609\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50609"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50609"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50609"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}